Atrix Laboratories, Inc. - ATRX- Profile

Atrix Laboratories, Inc.. The Group's principal activity is to develop drug delivery systems. The Group is currently developing a diverse portfolio of products including proprietary oncology, pain management and dermatology products. It has entered into strategic alliances with several pharmaceutical companies including Pfizer Inc, Sanofi-Synthelabo Inc, MediGene AG, Fujisawa Healthcare Inc, Elan International Services Ltd, Geneva Pharmaceuticals, Inc and CollaGenex Pharmaceuticals Inc. The Group currently markets two dental drug products, two medical device dental products and two over-the-counter products. Contract Revenue accounted for 45% of 2003 revenues; Pharmaceutical Product Sales and Royalties, 38% and Licensing Revenue, 17%